Modified lymphocytes that ectopically express an endogenous gene of interest, such as a gene encoding a chemokine cell surface receptor, are described. Also described are methods of producing the lymphocytes by delivery of transcriptional activator complexes, as well as methods of targeting cells with cognate chemokines, in order to treat various disorders.